Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Tsuji

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Biopharmaceutics & Drug Disposition|October 13, 2009
Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in miceSayaka Kato, Yukio Kato, Tadakatsu Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2012
ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrateNaoto Hashimoto, Noritaka Nakamichi, Shinya Uwafuji, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 26, 2004
Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cellsTakashi Nozawa, Masato Suzuki, Koichi Takahashi, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in ratsKazumasa Naruhashi, Ikumi Tamai, Natsuko Inoue, et al.
Drug Metabolism and Pharmacokinetics|October 30, 2007
Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in ratsYukihiro Yagi, Makoto Aoki, Maki Iguchi, et al.
Biopharmaceutics & Drug Disposition|November 5, 2003
Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2Akihiro Inano, Yoshimichi Sai, Hiroko Nikaido, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2008
P-glycoprotein (Abcb1) is involved in absorptive drug transport in skinKatsuaki Ito, Hai Thien Nguyen, Yukio Kato, et al.
International Journal of Pharmaceutics|December 31, 2005
Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasoneMingji Jin, Tsutomu Shimada, Koichi Yokogawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant proteinRikiya Ohashi, Ikumi Tamai, Akihiro Inano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 7, 2008
PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in miceTomoko Sugiura, Yukio Kato, Tomohiko Wakayama, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Biopharmaceutics & Drug Disposition|October 13, 2009
Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in miceSayaka Kato, Yukio Kato, Tadakatsu Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 24, 2012
ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrateNaoto Hashimoto, Noritaka Nakamichi, Shinya Uwafuji, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 26, 2004
Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cellsTakashi Nozawa, Masato Suzuki, Koichi Takahashi, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in ratsKazumasa Naruhashi, Ikumi Tamai, Natsuko Inoue, et al.
Drug Metabolism and Pharmacokinetics|October 30, 2007
Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in ratsYukihiro Yagi, Makoto Aoki, Maki Iguchi, et al.
Biopharmaceutics & Drug Disposition|November 5, 2003
Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2Akihiro Inano, Yoshimichi Sai, Hiroko Nikaido, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2008
P-glycoprotein (Abcb1) is involved in absorptive drug transport in skinKatsuaki Ito, Hai Thien Nguyen, Yukio Kato, et al.
International Journal of Pharmaceutics|December 31, 2005
Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasoneMingji Jin, Tsutomu Shimada, Koichi Yokogawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant proteinRikiya Ohashi, Ikumi Tamai, Akihiro Inano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 7, 2008
PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in miceTomoko Sugiura, Yukio Kato, Tomohiko Wakayama, et al.
Pageof 15